BioCentury
ARTICLE | Company News

Trinity buys Xtrana hemostasis division

November 12, 2001 8:00 AM UTC

Diagnostics play TRIB will acquire XTRN's hemostasis business for $6.3 million in cash and notes. The division includes test kits for blood coagulation, thrombotic risk factors, fibrinolysis, platelet...